<DOC>
	<DOCNO>NCT02415478</DOCNO>
	<brief_summary>For patient emphysema , lung volume reduction insertion endobronchial valve could expedient approach improve diaphragm function strength breathe muscle . Therefore present study investigator intend examine , whether lung volume reduction valve might improve physical capacity quality life .</brief_summary>
	<brief_title>Bronchioscopic Lung Volume Reduction ( BLVR )</brief_title>
	<detailed_description>In line routine exploration necessary clarify whether patient suitable lung volume reduction insertion endobronchial valve . To address question lung function diagnostics , 6-minutes-walk-test , blood withdrawal , CT thorax , lung perfusion scintigraphy transthoracic echocardiography perform . After confirmation suitability endoscopic lung volume reduction patient fulfill eligibility criterion educate aim performance study investigator . Following examination perform additional due study : determination strength breathe muscle via sniff nasal pressure ( PImax , PE max , P0.1 ) , determination life quality index via St.-George-questionary determination depression score via Short Form 8 ( SF-8 ) Health Survey . After endobronchial valve implant permanent post-operative examination perform 24 hour . Three , respectively nine month implant follow exploration perform study patient . Once determination strength breathe muscle , life quality index via St.-George-questionary depression score via SF-8 perform clarify improvement physical capacity quality life</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>bilateral lung emphysema CT previous guidelinesbased therapy COPD ( include vaccination Pneumococcal infection seasonal influenza ) nicotine abstention less three month , document COHB ( haemoglobin ) &lt; 2 % FEV 1 ( Forced Expiratory Volume 1 / one second capacity ) ≤ 45 % reference value , bronchodilatation total lung capacity ( TLC ) ≥ 100 % reference value residual volume ( RV ) ≥ 175 % reference value patient 's suitability endoscopic lung volume reduction accord multidisciplinary decision pneumology thorax surgery division . sign Informed Consent understanding nature , significance implication study ability understand follow instruction study stuff echocardiographic right ventricular pressure ( PAPsys ) &gt; 50 mmHg indication permanent anticoagulation therapy ( besides ASS ) pulmonal cachexia pregnancy lactate permanent treatment &gt; 20 mg Prednison per day hospitalisation due COPDexacerbation last 3 month &gt; 3 steroidtreated exacerbation last year Increase FEV1 ( Forced Expiratory Volume ) ≥ 20 % bronchodilatation severe diffusion impairment ( DLCO &lt; 20 % )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Chronic obstructive pulmonary disease ( COPD )</keyword>
	<keyword>endoscopic lung volume reduction</keyword>
	<keyword>Endobronchial valve</keyword>
	<keyword>physical capacity</keyword>
	<keyword>quality life</keyword>
</DOC>